Sensorion Reports Pipeline Update and First-Half-Year 2018 Results. Re-design of SENS-111 Study. pdfRead

Sensorion Reports Pipeline Update and First-Half-Year 2018 Results

Re-design of SENS-111 Study

Sensorion Announces Publication of Seliforant Phase 1 Study Data in the British Journal of Clinical Pharmacology. pdfRead

Sensorion to partner with Vestibular Disorders Association (VeDA) in sponsorship of Balance Awareness Week 2018 for vestibular disorders. pdfRead

Sensorion announces three poster presentations at the 55th Inner Ear Biology Workshop. pdfRead

Sensorion Receives European Authorization to Initiate SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss. pdfRead

Next events